for all manufacturing-related activities for GalXC™ and GalXC-Plus™ investigational therapeutics developed from Novo Nordisk's acquisition.... Are you ready to make a difference? The Position Novo Nordisk GNAT division is seeking a highly experienced and dynamic...
investigational therapeutics developed from Novo Nordisk’s acquisition of Dicerna Pharmaceuticals, Inc. in December 2021. With a new... innovation and manufacturing. Together, we are driving change. Are you ready to make a difference? The Position Novo Nordisk...
for all manufacturing-related activities for GalXC™ and GalXC-Plus™ investigational therapeutics developed from Novo Nordisk's acquisition... on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers...
investigational therapeutics developed from Novo Nordisk’s acquisition of Dicerna Pharmaceuticals, Inc. in December 2021. With a new... for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation...
activities for GalXC™ and GalXC-Plus™ investigational therapeutics developed from Novo Nordisk's acquisition of Dicerna... and staffing of the RNAi Chemical Development capability at Dicerna and Novo Nordisk. The incumbent will be highly experienced...
investigational therapeutics developed from Novo Nordisk’s acquisition of Dicerna Pharmaceuticals, Inc. in December 2021. With a new... capability at Dicerna and Novo Nordisk. The incumbent will be highly experienced process chemist, preferably with experience in...